Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C + arginine + magnesium sulfate in advanced lung cancer
ChiCTR2300074134Phase 2Recruiting
- Sponsor
- Yunnan Cancer Hospital
- Start
- Aug 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ascorbic acid, arginine and magnesium sulfate in bronchial carcinoma, sponsored by Yunnan Cancer Hospital. Primary endpoint: Treatment-related adverse events. Started Aug 2023; status: recruiting.
02
Drugs
ascorbic acidargininemagnesium sulfate
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2300074134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074134.